+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Isavuconazonium"

Isavuconazonium Sulfate Medicine Market by Indication (Invasive Aspergillosis, Mucormycosis), Route of Administration (Intravenous, Oral), Distribution Channel, End User, Form - Global Forecast 2025-2030 - Product Thumbnail Image

Isavuconazonium Sulfate Medicine Market by Indication (Invasive Aspergillosis, Mucormycosis), Route of Administration (Intravenous, Oral), Distribution Channel, End User, Form - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Yeast Infection Treatment Market Report 2025 - Product Thumbnail Image

Yeast Infection Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Aspergillosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Aspergillosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Isavuconazonium market is a subset of the Infectious Diseases Drugs market, focusing on the development and sale of drugs to treat fungal infections. Isavuconazonium is a broad-spectrum antifungal drug used to treat a variety of fungal infections, including those caused by Aspergillus and Candida species. It is available in both intravenous and oral formulations. The market is driven by the increasing prevalence of fungal infections, as well as the development of new drugs to treat them. The Isavuconazonium market is highly competitive, with a number of major pharmaceutical companies vying for market share. Companies in the market include Astellas Pharma, Basilea Pharmaceutica, Merck & Co., and Pfizer. Show Less Read more